Congress Unplugged presents Kathy Giusti, Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC).
Kathy Giusti is the Founder and Chief Executive Officer of the Multiple Myeloma Research Foundation (MMRF) and the Multiple Myeloma Research Consortium (MMRC). In 1998, following her diagnosis with multiple myeloma, Giusti founded the MMRF to fund innovative myeloma research and drug discovery. Having raised more than $120 million to date, the MMRF is the world's number one funder of myeloma research. As an extension of the MMRF's mission, Giusti founded the MMRC in 2004 to enable leading research institutions to work with industry to speed the discovery and development of effective new treatments. Comprising 15 academic institutions across North America, the MMRC is widely recognized for breaking down barriers in tissue banking, data management, genomics, and clinical trials, and is considered an optimal research model to accelerate the development of new therapies. To date, the MMRC has advanced 19 clinical trials of novel compounds and combination approaches through its clinical trials network.